{"id":8102,"date":"2022-08-02T16:11:04","date_gmt":"2022-08-02T16:11:04","guid":{"rendered":"https:\/\/www.dndial.org\/?page_id=8102"},"modified":"2026-03-02T17:35:39","modified_gmt":"2026-03-02T17:35:39","slug":"tratamientos-proporcionados","status":"publish","type":"page","link":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/","title":{"rendered":"Tratamientos proporcionados"},"content":{"rendered":"<div id=\"abertura-pagina-block_622777b0a66be\" class=\"abertura-pagina\">\n  <div id=\"showcase\" style=\"background-image:url(https:\/\/dndial.org\/wp-content\/uploads\/2025\/10\/tratament-1.png);background-color: #f5f5f5;\">\n    <div class=\"container\">\n      <div class=\"row\">\n        <div class=\"col-lg-12\">\n          <div class=\"breadcrumb mt-4 mb-5 futura font-12 text-white text-uppercase fw-bold\"><a href=\"https:\/\/dndial.org\/es\/\" rel=\"nofollow\">Home<\/a> &nbsp;&nbsp;&#187;&nbsp;&nbsp; Tratamientos proporcionados<\/div>\n        <\/div>\n      <\/div>\n      <div class=\"row row-inherit-height align-items-end hide-1024-down\">\n        <div class=\"col-lg-6\">\n          <div class=\"caption-orange\">\n            <h1 class=\"futura fw-bold font-26 text-white\">Tratamientos proporcionados<\/h1>\n            <p class=\"text-white font-20 din\">La DNDi ha desarrollado 14 nuevos tratamientos a partir de mol\u00e9culas existentes y recombinaci\u00f3n de f\u00e1rmacos contra la malaria, la enfermedad de Chagas, la leishmaniasis, la coinfecci\u00f3n VIH-leishmaniasis visceral y el VIH pedi\u00e1trico.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n  <div class=\"row hide-1024-up\">\n    <div class=\"col-xl-6\">\n      <div class=\"caption-orange\">\n        <h1 class=\"futura fw-bold font-26 text-white\">Tratamientos proporcionados<\/h1>\n        <p class=\"text-white font-20 din\">La DNDi ha desarrollado 14 nuevos tratamientos a partir de mol\u00e9culas existentes y recombinaci\u00f3n de f\u00e1rmacos contra la malaria, la enfermedad de Chagas, la leishmaniasis, la coinfecci\u00f3n VIH-leishmaniasis visceral y el VIH pedi\u00e1trico.<\/p>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/div>\n\n            <div id=\"titulo-e-texto-block_6227785ea66bf\"\n    class=\"titulo-e-texto pb-5 bg-white pt-80 pb-80\">\n    <div class=\"container\">\n        <div class=\"row\">\n            <div class=\"col-lg-8 offset-lg-2\">\n                <h2 class=\"futura fw-bold lh-base font-24 mb-4\">\n                    Ofrecemos mejores tratamientos para pacientes desatendidos                <\/h2>\n                                <p>El objetivo de la DNDi es ofrecer 25 nuevos tratamientos para pacientes desatendidos hasta 2028.<\/p>\n<p>Desde 2003, la DNDi ha trabajado en alianza con su red mundial de socios para desarrollar:<\/p>\n<ul>\n<li aria-level=\"1\">tres entidades qu\u00edmicas: el <a href=\"https:\/\/dndial.org\/es\/releases\/2026\/acoziborole-winthrop-desarrollado-por-dndi-y-sanofi-recibe-una-opinion-favorable-de-la-agencia-europea-de-medicamentos-como-un-tratamiento-de-dosis-unica-para-la-forma-mas-comun-de-la-enfermedad-del\/\">acoziborol<\/a>, un tratamiento oral de dosis \u00fanica para la enfermedad del sue\u00f1o gambiense, el <a href=\"https:\/\/dndial.org\/es\/releases\/2023\/ema-da-opinion-positiva-al-fexinidazol-winthrop-como-primer-tratamiento-oral-para-la-forma-aguda-de-la-enfermedad-del-sueno-rhodesiense-que-se-encuentra-en-africa-oriental-y-meridional\/\">fexinidazol<\/a>, el primer tratamiento totalmente oral para la enfermedad del sue\u00f1o, y el <a href=\"https:\/\/dndi.org\/research-development\/portfolio\/ravidasvir-sofosbuvir\/\">ravidasvir<\/a>, un tratamiento asequible y f\u00e1cil de usar para la hepatitis C<\/li>\n<li aria-level=\"1\">10 nuevos tratamientos para la malaria, la enfermedad de Chagas, las leishmaniasis, la coinfecci\u00f3n VIH-leishmaniasis visceral y el VIH pedi\u00e1trico a partir de mol\u00e9culas ya existentes o del reposicionamiento de f\u00e1rmacos.<\/li>\n<\/ul>\n<p>Tambi\u00e9n ha fundado <a href=\"https:\/\/gardp.org\/\" target=\"_blank\" rel=\"noopener\">GARDP<\/a>, una organizaci\u00f3n de investigaci\u00f3n y desarrollo sin fines de lucro que desarrolla y ofrece tratamientos antibi\u00f3ticos nuevos o mejorados.<\/p>\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<section id=\"timeline\" class=\"\">\n  <div class=\"container\">\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2026<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2026\/03\/pill.png\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Acoziborol<\/h3>\n            <p><a href=\"https:\/\/dndial.org\/es\/releases\/2026\/acoziborole-winthrop-desarrollado-por-dndi-y-sanofi-recibe-una-opinion-favorable-de-la-agencia-europea-de-medicamentos-como-un-tratamiento-de-dosis-unica-para-la-forma-mas-comun-de-la-enfermedad-del\/\">Una cura revolucionaria, de dosis \u00fanica, para <em>T.b. gambiense<\/em><\/a><\/p>\n<p>Alianza con Sanofi, la Plataforma HAT y los programas nacionales de control.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2023<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2023\/12\/SleepingSickness-Malawi-202306-174-3-1.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Fexinidazol para la enfermedad del sue\u00f1o por T. B. rhodesiense<\/h3>\n            <p><a href=\"https:\/\/dndial.org\/es\/releases\/2023\/ema-da-opinion-positiva-al-fexinidazol-winthrop-como-primer-tratamiento-oral-para-la-forma-aguda-de-la-enfermedad-del-sueno-rhodesiense-que-se-encuentra-en-africa-oriental-y-meridional\/\">Cura oral segura y eficaz para la forma aguda de la enfermedad del sue\u00f1o.<\/a><\/p>\n<p>Asociaci\u00f3n con Sanofi y el consorcio HAT-r-ACC<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2022<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2023\/11\/DNDi_Leishmaniasis_Brazil_2018_SiraneandDaniel22-redimensionada.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Nuevas recomendaciones para el tratamiento de la leishmaniasis visceral en Am\u00e9rica Latina<\/h3>\n            <p><a href=\"https:\/\/dndial.org\/es\/doencas\/leishmaniasis-visceral\/\"><strong>Anfotericina B liposomal recomendada en lugar de antimoniales pentavalentes.<\/strong><\/a><\/p>\n<p>Colaboraci\u00f3n con la Universidad de Brasilia y la Fundaci\u00f3n Oswaldo Cruz de Brasil.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2022<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2023\/07\/PaediatricHIV-4-in-1_12.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Nuevos tratamientos para el VIH\/LV<\/h3>\n            <p><strong>Mejor tratamiento para las personas coinfectadas por el VIH y la leishmaniasis visceral.<\/strong><\/p>\n<p>Alianza con M\u00e9dicos Sin Fronteras y otros socios.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2022<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2023\/07\/DNDi_Leishmanasis_Brazil_2018_ViniciusBerger_10.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Tratamiento antirretroviral 4 en 1<\/h3>\n            <p>Tratamiento dise\u00f1ado espec\u00edficamente para beb\u00e9s y ni\u00f1os peque\u00f1os con VIH.<\/p>\n<p>Alianza con Cipla Limited.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2021<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_01.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Ravidasvir<\/h3>\n            <p><strong>Un tratamiento asequible para la hepatitis C<\/strong><\/p>\n<p>Alianza con los ministerios de salud de Malasia y Tailandia, <a href=\"http:\/\/pharmaniaga.com\/\" target=\"_blank\" rel=\"noopener\">Pharmaniaga<\/a>, <a href=\"https:\/\/www.pharco.org\/\" target=\"_blank\" rel=\"noopener\">Pharco Pharmaceuticals<\/a> y <a href=\"https:\/\/www.msf.org\/\" target=\"_blank\" rel=\"noopener\">Medicos Sin Fronteras (Francia)<\/a><\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2018<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_02.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Fexinidazol<\/h3>\n            <p><strong>El primer tratamiento totalmente oral que cura todas las fases de la enfermedad del sue\u00f1o<\/strong><\/p>\n<p>Alianza con <a href=\"https:\/\/www.sanofi.com.br\/\" target=\"_blank\" rel=\"noopener\">Sanofi<\/a>, la Plataforma de Tripanosomiasis Humana Africana, <a href=\"http:\/\/www.msf.org\" target=\"_blank\" rel=\"noopener\">M\u00e9dicos Sin Fronteras<\/a>, programas nacionales de control y la OMS<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2018<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_03.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">GARDP<\/h3>\n            <p>Incubaci\u00f3n de la Global Antibiotic Research and Development Partnership (<a href=\"https:\/\/gardp.org\/\" target=\"_blank\" rel=\"noopener\">GARDP<\/a>, Asociaci\u00f3n Mundial para la Investigaci\u00f3n y el Desarrollo de Antibi\u00f3ticos) para hacer frente a la resistencia a los antimicrobianos<\/p>\n<p>Alianza con la OMS<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2016<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_04.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Terapia superbooster<\/h3>\n            <p>Tratamiento m\u00e1s eficaz para ni\u00f1os con VIH y tuberculosis.<\/p>\n<p>Alianza con el <a href=\"http:\/\/www.health.gov.za\/\" target=\"_blank\" rel=\"noopener\">Departamento de Salud de Sud\u00e1frica<\/a>.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2011<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_06.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Benznidazol pedi\u00e1trico<\/h3>\n            <p>Primer medicamento pedi\u00e1trico para la enfermedad de Chagas.<\/p>\n<p>Alianza con <a href=\"https:\/\/www.lafepe.pe.gov.br\/\" target=\"_blank\" rel=\"noopener\">LAFEPE<\/a> (Brasil) para desarrollar el primer tratamiento pedi\u00e1trico para Chagas (2011); alianzas posteriores con <a href=\"https:\/\/www.exeltis.com\/insud-pharma-new-name-chemo-group\" target=\"_blank\" rel=\"noopener\">Chemo Research, Exeltis USA<\/a>, <a href=\"https:\/\/www.mundosano.org\/es\/\" target=\"_blank\" rel=\"noopener\">Fundaci\u00f3n Mundo Sano<\/a> y <a href=\"https:\/\/elea.com\/\" target=\"_blank\" rel=\"noopener\">Laboratorio ELEA<\/a> PHOENIX.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2011<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_05.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Nuevos tratamientos para la leishmaniasis visceral en Asia<\/h3>\n            <p>Mejores tratamientos en Asia Meridional.<\/p>\n<p>Alianzas con actores involucrados en leishmaniasis visceral en Asia Meridional, como ministerios de salud, institutos de investigaci\u00f3n, ONG y el TRD\/OMS.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2010<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_07.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">SSG&#038;PM<\/h3>\n            <p>Un tratamiento m\u00e1s econ\u00f3mico y eficaz para la leishmaniasis visceral en \u00c1frica<\/p>\n<p>Alianza con la Plataforma de Leishmaniasis de \u00c1frica Oriental (<a href=\"https:\/\/www.youtube.com\/watch?v=xMN3DjjjPm0\" target=\"_blank\" rel=\"noopener\">LEAP<\/a>), programas nacionales de control, M\u00e9dicos Sin Fronteras y la OMS.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2009<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_08.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">Terapia de combinaci\u00f3n de nifurtimox-eflornitina (NECT)<\/h3>\n            <p>Un tratamiento mejor y m\u00e1s seguro para la enfermedad del sue\u00f1o.<\/p>\n<p>Alianza con M\u00e9dicos Sin Fronteras, <a href=\"https:\/\/epicentre.msf.org\/en\" target=\"_blank\" rel=\"noopener\">Epicentre<\/a>, programas nacionales de control y la OMS.<\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2008<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_09.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">ASMQ*<\/h3>\n            <p>Combinaci\u00f3n de dosis fija de artesunato y mefloquina para la malaria.<\/p>\n<p>Alianza con <a href=\"https:\/\/www.far.fiocruz.br\/\" target=\"_blank\" rel=\"noopener\">Farmanguinhos\/Fiocruz<\/a> (Brasil) y <a href=\"https:\/\/www.cipla.com\/\" target=\"_blank\" rel=\"noopener\">Cipla<\/a> (India).<\/p>\n<p><em>*Proyecto transferido a la iniciativa Medicines for Malaria Venture en 2015.<\/em><\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n        <div class=\"row timeline-item\">\n      <div class=\"col-lg-5 offset-lg-1 px-0\">\n        <div class=\"card-wrap\">\n          <p class=\"ano futura fw-bold font-24 orange-01\">2007<\/p>\n          <div class=\"tl-card\">\n            <img decoding=\"async\" src=\"https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/timeline_19.jpg\" alt=\"Tratamientos proporcionados\" class=\"img-fluid\">\n            <h3 class=\"orange-01 futura font-24 fw-bold mt-2\">ASAQ*<\/h3>\n            <p>Combinaci\u00f3n de dosis fija de artesunato y amodiaquina para tratar la malaria.<\/p>\n<p>En alianza con Sanofi.<\/p>\n<p><em>*Proyecto transferido a la iniciativa Medicines for Malaria Venture en 2015.<\/em><\/p>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n      <\/div>\n<\/section>\n<script>\n$(\".timeline-item:even\").find(\".col-lg-5\").addClass(\"offset-lg-6\");\n<\/script>\n\n    <div id=\"titulo-resumo-botao-bgimg-block_6228bc0150630\" class=\"titulo-resumo-botao-bgimg  \">\n  <section style=\"background-image:url(https:\/\/dndial.org\/wp-content\/uploads\/2022\/03\/bg_doacao.jpg)\">\n    <div class=\"container\">\n      <div class=\"row align-items-center\">\n        <div class=\"col-lg-8 offset-lg-2\">\n          <div class=\"box\">\n            <h2 class=\"text-white text-center futura fw-bold font-40 mb-3\">Ayuda para pacientes desatendidos<\/h2>\n            <span class=\"text-white text-center din font-20\">\n              <p>Brindamos hasta el momento 14 nuevos tratamientos para enfermedades desatendidas, salvando millones de vidas.<br \/>\r\nNuestro objetivo es ofrecer 25 nuevos tratamientos en nuestros primeros 25 a\u00f1os. Con su ayuda, podemos lograrlo.<\/p>\n            <\/span>\n            <div class=\"d-grid d-md-flex justify-content-md-center mt-5\">\n                            <a class=\"btn btn-black-outline-white font-12 px-4\" href=\"https:\/\/www.dndial.org\/faca-uma-doacao\/\"\n                target=\"_self\">\u00a1HAZ TU DONACI\u00d3N!  <i class=\"fas fa-arrow-right\"><\/i><\/a>\n            <\/div>\n          <\/div>\n        <\/div>\n      <\/div>\n    <\/div>\n  <\/section>\n\n  <style type=\"text\/css\">\n  #titulo-resumo-botao-bgimg-block_6228bc0150630 {\n    background: ;\n    color: ;\n  }\n  <\/style>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":8087,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8102","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_ES\" \/>\n\t\t<meta property=\"og:site_name\" content=\"DNDi Am\u00e9rica Latina | Iniciativa Medicamentos  para Doen\u00e7as Negligenciadas\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Tratamientos proporcionados | DNDi Am\u00e9rica Latina\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/dndial.org\/wp-content\/uploads\/2023\/03\/dndi-socialmedia-logo-notag.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/dndial.org\/wp-content\/uploads\/2023\/03\/dndi-socialmedia-logo-notag.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-08-02T16:11:04+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-03-02T17:35:39+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/dndi.org\/\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/tratamientos-proporcionados\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/#listItem\",\"position\":1,\"name\":\"In\\u00edcio\",\"item\":\"https:\\\/\\\/dndial.org\\\/es\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/#listItem\",\"name\":\"Nuestros proyectos\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/#listItem\",\"position\":2,\"name\":\"Nuestros proyectos\",\"item\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/tratamientos-proporcionados\\\/#listItem\",\"name\":\"Tratamientos proporcionados\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/#listItem\",\"name\":\"In\\u00edcio\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/tratamientos-proporcionados\\\/#listItem\",\"position\":3,\"name\":\"Tratamientos proporcionados\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/#listItem\",\"name\":\"Nuestros proyectos\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/#organization\",\"name\":\"DNDi Am\\u00e9rica Latina\",\"description\":\"Iniciativa Medicamentos  para Doen\\u00e7as Negligenciadas\",\"url\":\"https:\\\/\\\/dndial.org\\\/es\\\/\",\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/dndi.org\\\/\",\"https:\\\/\\\/twitter.com\\\/DNDi_Espanol\",\"https:\\\/\\\/www.instagram.com\\\/drugsforneglecteddiseases\\\/\",\"https:\\\/\\\/www.youtube.com\\\/dndiconnect\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dndi\"]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/tratamientos-proporcionados\\\/#webpage\",\"url\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/tratamientos-proporcionados\\\/\",\"name\":\"Tratamientos proporcionados | DNDi Am\\u00e9rica Latina\",\"inLanguage\":\"es-ES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/nuestros-proyectos\\\/tratamientos-proporcionados\\\/#breadcrumblist\"},\"datePublished\":\"2022-08-02T16:11:04+00:00\",\"dateModified\":\"2026-03-02T17:35:39+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/dndial.org\\\/es\\\/\",\"name\":\"DNDi Am\\u00e9rica Latina\",\"description\":\"Iniciativa Medicamentos  para Doen\\u00e7as Negligenciadas\",\"inLanguage\":\"es-ES\",\"publisher\":{\"@id\":\"https:\\\/\\\/dndial.org\\\/es\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Tratamientos proporcionados | DNDi Am\u00e9rica Latina","description":"","canonical_url":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/dndial.org\/es\/#listItem","position":1,"name":"In\u00edcio","item":"https:\/\/dndial.org\/es\/","nextItem":{"@type":"ListItem","@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/#listItem","name":"Nuestros proyectos"}},{"@type":"ListItem","@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/#listItem","position":2,"name":"Nuestros proyectos","item":"https:\/\/dndial.org\/es\/nuestros-proyectos\/","nextItem":{"@type":"ListItem","@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/#listItem","name":"Tratamientos proporcionados"},"previousItem":{"@type":"ListItem","@id":"https:\/\/dndial.org\/es\/#listItem","name":"In\u00edcio"}},{"@type":"ListItem","@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/#listItem","position":3,"name":"Tratamientos proporcionados","previousItem":{"@type":"ListItem","@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/#listItem","name":"Nuestros proyectos"}}]},{"@type":"Organization","@id":"https:\/\/dndial.org\/es\/#organization","name":"DNDi Am\u00e9rica Latina","description":"Iniciativa Medicamentos  para Doen\u00e7as Negligenciadas","url":"https:\/\/dndial.org\/es\/","sameAs":["https:\/\/www.facebook.com\/dndi.org\/","https:\/\/twitter.com\/DNDi_Espanol","https:\/\/www.instagram.com\/drugsforneglecteddiseases\/","https:\/\/www.youtube.com\/dndiconnect","https:\/\/www.linkedin.com\/company\/dndi"]},{"@type":"WebPage","@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/#webpage","url":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/","name":"Tratamientos proporcionados | DNDi Am\u00e9rica Latina","inLanguage":"es-ES","isPartOf":{"@id":"https:\/\/dndial.org\/es\/#website"},"breadcrumb":{"@id":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/#breadcrumblist"},"datePublished":"2022-08-02T16:11:04+00:00","dateModified":"2026-03-02T17:35:39+00:00"},{"@type":"WebSite","@id":"https:\/\/dndial.org\/es\/#website","url":"https:\/\/dndial.org\/es\/","name":"DNDi Am\u00e9rica Latina","description":"Iniciativa Medicamentos  para Doen\u00e7as Negligenciadas","inLanguage":"es-ES","publisher":{"@id":"https:\/\/dndial.org\/es\/#organization"}}]},"og:locale":"es_ES","og:site_name":"DNDi Am\u00e9rica Latina | Iniciativa Medicamentos  para Doen\u00e7as Negligenciadas","og:type":"article","og:title":"Tratamientos proporcionados | DNDi Am\u00e9rica Latina","og:url":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/","og:image":"https:\/\/dndial.org\/wp-content\/uploads\/2023\/03\/dndi-socialmedia-logo-notag.jpg","og:image:secure_url":"https:\/\/dndial.org\/wp-content\/uploads\/2023\/03\/dndi-socialmedia-logo-notag.jpg","og:image:width":1200,"og:image:height":675,"article:published_time":"2022-08-02T16:11:04+00:00","article:modified_time":"2026-03-02T17:35:39+00:00","article:publisher":"https:\/\/www.facebook.com\/dndi.org\/"},"aioseo_meta_data":{"post_id":"8102","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_custom_image_width":null,"og_custom_image_height":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":"{\"article\":{\"articleType\":\"BlogPosting\"},\"course\":{\"name\":\"\",\"description\":\"\",\"provider\":\"\"},\"faq\":{\"pages\":[]},\"product\":{\"reviews\":[]},\"recipe\":{\"ingredients\":[],\"instructions\":[],\"keywords\":[]},\"software\":{\"reviews\":[],\"operatingSystems\":[]},\"webPage\":{\"webPageType\":\"WebPage\"},\"blockGraphs\":[]}","pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"none","tabs":null,"priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"created":"2022-08-02 16:11:05","updated":"2026-08-15 06:04:48","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"twitter_image_url":null,"limit_modified_date":false,"ai":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/dndial.org\/es\/\" title=\"In\u00edcio\">In\u00edcio<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/dndial.org\/es\/nuestros-proyectos\/\" title=\"Nuestros proyectos\">Nuestros proyectos<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tTratamientos proporcionados\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"In\u00edcio","link":"https:\/\/dndial.org\/es\/"},{"label":"Nuestros proyectos","link":"https:\/\/dndial.org\/es\/nuestros-proyectos\/"},{"label":"Tratamientos proporcionados","link":"https:\/\/dndial.org\/es\/nuestros-proyectos\/tratamientos-proporcionados\/"}],"_links":{"self":[{"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/pages\/8102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/comments?post=8102"}],"version-history":[{"count":51,"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/pages\/8102\/revisions"}],"predecessor-version":[{"id":17916,"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/pages\/8102\/revisions\/17916"}],"up":[{"embeddable":true,"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/pages\/8087"}],"wp:attachment":[{"href":"https:\/\/dndial.org\/es\/wp-json\/wp\/v2\/media?parent=8102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}